Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
111, Inc. Reaches Strategic Partnership on Direct Supply with Beilin Pharmaceutical to Blaze New Trails in Digital Development of Chinese Patent Medicine 2022-03-04 17:24
Genome and Company announces Clinical Trial Collaboration with MSD to evaluate 'GEN-001' in combination of KEYTRUDA® (pembrolizumab) in phase 2 clinical trial in biliary tract cancer patients 2022-03-04 09:30
Scientific leaders signal major breakthroughs in elimination of cervical and anal cancers 2022-03-04 08:01
Claudin18.2 CAR T Cells (CT041) Receives Approval to Initiate A Confirmatory Phase II Clinical Trial for advanced GC/GEJ in China 2022-03-03 21:50
I-Mab Receives FDA Orphan Drug Designation for its Novel Claudin 18.2 x 4-1BB Bispecific Antibody TJ-CD4B for the Treatment of Gastric Cancer 2022-03-03 21:00
CNN's Vital Signs explores the future of medicine 2022-03-03 10:13
Sequential Skin debuts Sequential Bio - the world's first in-vivo microbiome testing solution for skin, hair, and personal product industries. 2022-03-03 07:55
Akeso Announces Clinical Trial Collaboration with Chipscreen Biosciences to Evaluate Cadonilimab in Combination with Chiauranib for Extensive-Stage Small-Cell Lung Cancer 2022-03-03 01:34
Zhongshan Chenxinghai Hospital, Hong Kong Integrated Oncology Centre and healthcare distributor DCH Auriga partner to provide Hong Kong-approved medical treatments to GBA patients 2022-03-02 20:02
Seegene appoints Richard Creager as CEO of U.S. subsidiary to bolster U.S. business 2022-03-02 20:00
Adagene Announces SAFEbody® Multi-Target Collaboration with Sanofi for Novel Masked Immuno-Oncology Antibody Candidates 2022-03-02 19:00
Intellect offers free access to healthcare workers to support mental well-being during surge in healthcare demand 2022-03-02 17:56
REDCLOUD BIO ANNOUNCES FDA ACCEPTANCE OF IND APPLICATION FOR NEXT-GENERATION EGFR INHIBITOR H002 IN NON-SMALL CELL LUNG CANCER 2022-03-02 17:27
InnoCare Announces Approval of Phase II Clinical Trial Using Orelabrutinib for the Treatment of NMOSD in China 2022-03-02 10:37
WuXi Biologics Wins CMO Leadership Awards in All Six Core Categories for Fifth Consecutive Year 2022-03-02 10:07
Malaysian-Made ProDetect(R) Rapid Test-Kit Scores 100% Accuracy in International Assessment 2022-03-02 09:15
ImmVira's breakthrough intravenous oncolytic virus product MVR-T3011 IV completed first dosing in Phase I clinical trial in China 2022-03-02 09:07
Antengene Announces XPOVIO® Regulatory Approval in Singapore for the Treatment of Relapsed and/or Refractory Multiple Myeloma and Relapsed/Refractory Diffuse Large B-Cell Lymphoma in Three Indications 2022-03-02 08:47
Amrita University launch wearable device for home monitoring of glucose and BP 2022-03-02 07:40
The Sigourney Trust Issues Call For Entries Of Psychoanalytic Work Eligible To Win The Sigourney Award-2022 2022-03-01 22:15
1 275 276 277 278 279 890